Table 1 Biodistribution of [131I]SGMIB-2Rs15d in NOD SCID mice bearing BT474 xenografts.

From: Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers

Percent injected dose per gram of tissuea

Tissues

1 h

4 h

8 h

16 h

24 h

Liver

5.3 ± 0.7

3.5 ± 0.8

2.2 ± 0.1

0.1 ± 0.0

0.0 ± 0.0

Spleen

1.2 ± 0.3

1.5 ± 0.9

0.6 ± 0.2

0.1 ± 0.0

0.0 ± 0.0

Lungs

2.8 ± 0.8

2.5 ± 1.0

1.2 ± 0.4

1.3 ± 0.7

0.1 ± 0.1

Heart

0.7 ± 0.3

0.3 ± 0.2

0.2 ± 0.1

0.0 ± 0.0

0.0 ± 0.0

Kidneys

74.1 ± 14.2

15.4 ± 7.1

7.1 ± 4.9

0.6 ± 0.3

0.5 ± 0.2

Stomach

1.1 ± 0.4

1.0 ± 0.8

0.9 ± 0.5

0.3 ± 0.3

0.1 ± 0.0

Thyroid

0.4 ± 0.3

0.4 ± 0.2

0.3 ± 0.2

0.1 ± 0.0

0.1 ± 0.1

Sm. Int

1.1 ± 0.3

1.4 ± 0.7

2.4 ± 4.0

0.3 ± 0.3

0.1 ± 0.0

Lg. Int

0.3 ± 0.1

2.2 ± 1.8

5.0 ± 3.6

0.9 ± 0.5

0.2 ± 0.1

Muscle

0.4 ± 0.1

0.1 ± 0.1

0.1 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

Blood

1.5 ± 0.5

0.8 ± 0.2

0.5 ± 0.3

0.0 ± 0.0

0.0 ± 0.0

Bone

0.5 ± 0.2

0.2 ± 0.1

0.1 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

Brain

0.1 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

Tumor

17.1 ± 6.0

17.7 ± 4.7

11.0 ± 2.3

8.5 ± 2.2

5.7 ± 1.3

  1. aMean ± SD (n = 5).